Harriet Kluger MD
Associate Professor of Medicine (Medical Oncology); Associate Director, Hematology/Oncology Fellowship Program
Departments & Organizations
Yale Medical GroupCancer Center, Yale: Prostate and Urologic Cancers Program | Melanoma Program | Developmental Therapeutics
Skin Diseases Research Center, Yale
Medical Oncology
Immunology and Immunotherapy
Medical Oncology
Biography
Dr. Kluger is a medical oncologist who sees patients with melanoma, renal cell carcinoma and breast cancer. Her research interests focus on developing new drugs and biomarkers predictive of response to these drugs in melanoma and renal cell carcinoma. She participates in a number of clinical trials studying new agents for the treatment of these diseases, both targeting the immune system and the cancer cell. She runs and active research laboratory that studies tumors and cells from patients treated with novel therapies.
See Full Profile
Education
- M.D., Tel Aviv University , 1993
Selected Publication
- C-Raf is Associated with Disease Progression and Inhibition of Apoptosis in a Subset of Melanomas Jilaveanu LB, Zito C, Aziz SA, Schmitz JC, Sznol M, Camp RL, Rimm DL, and Kluger HM 2009 Sep 15;15(18):5704-13, Clinical Cancer Research
Articles
June 2012
Turning on immunity to shut off cancer
When Lieping Chen, M.D., Ph.D., was training to be an oncologist in the 1980s, the lack of effective cancer treatments...
Medicine@Yale, the bimonthly newsletter of Yale School of Medicine (YSM), chronicles achievements
of YSM in basic and clinical research, medical education, and health care. Read More...
